Lum LG - Search Results

1

Activated T cells armed with bispecific antibodies kill tumor targets.

Bhutani D, Lum LG. Bhutani D, et al. Among authors: lum lg. Curr Opin Hematol. 2015 Nov;22(6):476-83. doi: 10.1097/MOH.0000000000000176. Curr Opin Hematol. 2015. PMID: 26457960 Review.

2

Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.

Ueda M, Joshi ID, Dan M, Uberti JP, Chou TH, Sensenbrenner LL, Lum LG. Ueda M, et al. Among authors: lum lg. Transplantation. 1993 Aug;56(2):351-6. Transplantation. 1993. PMID: 8356589

3

T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.

Gall JM, Davol PA, Grabert RC, Deaver M, Lum LG. Gall JM, et al. Among authors: lum lg. Exp Hematol. 2005 Apr;33(4):452-9. doi: 10.1016/j.exphem.2005.01.007. Exp Hematol. 2005. PMID: 15781336 Free article.

4

The new face of bispecific antibodies: targeting cancer and much more.

Lum LG, Davol PA, Lee RJ. Lum LG, et al. Exp Hematol. 2006 Jan;34(1):1-6. doi: 10.1016/j.exphem.2005.07.013. Exp Hematol. 2006. PMID: 16413384 Free article. Review.

5

Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation.

Grabert RC, Cousens LP, Smith JA, Olson S, Gall J, Young WB, Davol PA, Lum LG. Grabert RC, et al. Among authors: lum lg. Clin Cancer Res. 2006 Jan 15;12(2):569-76. doi: 10.1158/1078-0432.CCR-05-2005. Clin Cancer Res. 2006. PMID: 16428502

6

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.

Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Chan JK, et al. Among authors: lum lg. Clin Cancer Res. 2006 Mar 15;12(6):1859-67. doi: 10.1158/1078-0432.CCR-05-2019. Clin Cancer Res. 2006. PMID: 16551871

7

Cancer therapy with bispecific antibodies: Clinical experience.

Thakur A, Lum LG. Thakur A, et al. Among authors: lum lg. Curr Opin Mol Ther. 2010 Jun;12(3):340-9. Curr Opin Mol Ther. 2010. PMID: 20521223 Free PMC article. Review.

8

In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.

Thakur A, Norkina O, Lum LG. Thakur A, et al. Among authors: lum lg. Cancer Immunol Immunother. 2011 Dec;60(12):1707-20. doi: 10.1007/s00262-011-1056-9. Epub 2011 Jun 29. Cancer Immunol Immunother. 2011. PMID: 21713642 Free PMC article.

9

Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.

Thakur A, Sorenson C, Norkina O, Schalk D, Ratanatharathorn V, Lum LG. Thakur A, et al. Among authors: lum lg. Transfusion. 2012 Jan;52(1):63-75. doi: 10.1111/j.1537-2995.2011.03232.x. Epub 2011 Jul 11. Transfusion. 2012. PMID: 21745212 Free PMC article.

10

A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells.

Thakur A, Schalk D, Sarkar SH, Al-Khadimi Z, Sarkar FH, Lum LG. Thakur A, et al. Among authors: lum lg. Cancer Immunol Immunother. 2012 Apr;61(4):497-509. doi: 10.1007/s00262-011-1116-1. Epub 2011 Oct 5. Cancer Immunol Immunother. 2012. PMID: 21971587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters